State of Tennessee, Department of Treasury’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Sell
48,970
-535
-1% -$12.8K ﹤0.01% 1161
2025
Q4
$1.24M Sell
49,505
-4,613
-9% -$110K ﹤0.01% 1118
2025
Q3
$1.15M Buy
54,118
+210
+0.4% +$4.97K ﹤0.01% 1138
2025
Q2
$1.16M Sell
53,908
-2,144
-4% -$39.9K ﹤0.01% 1089
2025
Q1
$931K Buy
+56,052
New +$1.02M ﹤0.01% 1181

Other funds holding ACAD

State of Tennessee, Department of Treasury's ACAD Position: Q1 2026 in Review

State of Tennessee, Department of Treasury reduced its Acadia Pharmaceuticals (ACAD) stake by 1.1% in Q1 2026, selling an estimated $12.8K and leaving 48,970 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1161.

State of Tennessee, Department of Treasury first reported a position in ACAD in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.24M in Q4 2025. 342 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • State of Tennessee, Department of Treasury held 48,970 shares of Acadia Pharmaceuticals worth $1.09M as of Q1 2026.
  • State of Tennessee, Department of Treasury sold 535 Acadia Pharmaceuticals shares in Q1 2026, an estimated $12.8K.
  • Acadia Pharmaceuticals made up ﹤0.01% of State of Tennessee, Department of Treasury's portfolio in Q1 2026, its #1161 holding.
  • State of Tennessee, Department of Treasury first reported a position in Acadia Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • State of Tennessee, Department of Treasury's Acadia Pharmaceuticals position peaked at $1.24M in Q4 2025.
  • 342 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2026, filed 15 May 2026.